Kirsten F. Bostwick (Johnson)
About Kirsten F. Bostwick (Johnson)
Kirsten F. Bostwick (Johnson) is a Principal Scientist at Bristol Myers Squibb in Summit, NJ, with a background in organic chemistry and extensive experience in both academic and industrial research.
Current Position at Bristol Myers Squibb
Kirsten F. Bostwick (Johnson) currently holds the position of Principal Scientist at Bristol Myers Squibb in Summit, NJ. In this role, she continues to build on her extensive experience in organic chemistry and pharmaceutical research.
Tenure at Celgene
Kirsten F. Bostwick worked at Celgene as Scientist II from 2016 to 2021, spending five years in Summit, NJ. During her tenure, she contributed significantly to the company's research endeavors, particularly in the field of organic chemistry.
Academic and Research Background
Kirsten has a robust academic background, having studied at Iowa State University, where she earned her Ph.D. in Organic Chemistry between 2011 and 2016. As an undergraduate, she studied Chemistry and Spanish at the University of Wisconsin-Madison, completing her Bachelor of Science degree from 2007 to 2011. Kirsten's research contributions include developing a novel rhodium catalyst for the enantioselective hydroacylation of ortho-allylbenzaldehydes and investigating the hydroacylation of polysubstituted olefins.
Early Research Positions
Before her role at Bristol Myers Squibb, Kirsten held several important positions. From 2011 to 2016, she served as Head TA - Organic Chemistry at Iowa State University. Prior to that, she worked in the Gopalan Group at the University of Wisconsin-Madison as an Undergraduate Researcher from 2009 to 2011.
Published Catalytic Research
Kirsten F. Bostwick has developed three distinct protocols for the synthesis of N-tert-prenylindoles by palladium-catalyzed allylic substitution. Her published work includes identifying a rhodium catalyst for the enantioselective hydroacylation of trisubstituted cycloalkenes and developing a novel rhodium catalyst for hydroacylation that minimizes byproduct formation through catalyst design.